New Two-Drug attack targets Tough-to-Treat cancers
NCT ID NCT05194995
Summary
This study is testing a new oral drug, JAB-21822, combined with an existing cancer drug called cetuximab. It is for people with advanced colorectal, small intestine, or appendix cancers that have a specific genetic change called KRAS G12C. The main goals are to find a safe and effective dose and to see if the combination can shrink tumors in patients who have already tried at least one standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site01
Beijing, Beijing Municipality, 100101, China
-
Research site02
Beijing, Beijing Municipality, 100101, China
-
Research site05
Zhengzhou, Henan, 450000, China
-
Research site06
Harbin, Heilongjiang, 150000, China
-
Research site07
Zhengzhou, Henan, 450000, China
-
Research site08
Nanchang, Jiangxi, 330000, China
-
Research site09
Nanjing, Jiangsu, 210000, China
-
Research site11
Changsha, Hunan, 410000, China
-
Research site12
Beijing, Beijing Municipality, 100101, China
-
Research site13
Nanning, Guangxi, 530021, China
-
Research site16
Linyi, Shandong, 276002, China
-
Research site18
Wuhan, Hubei, 430079, China
-
Research site19
Hangzhou, Zhejiang, 310005, China
-
Research site23
Xi’an, Shanxi, 710000, China
-
Research site28
Shanghai, Shanghai Municipality, 200032, China
-
Research site29
Changsha, Hunan, 410000, China
-
Research site31
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.